Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:28 pm Purchase |
2021-12-31 | 13G | enVVeno Medical Corporation NVNO |
CVI Investments, Inc. | 280,357 2.900% |
280,357 (New Position) |
Filing History |
| 2022-02-14 3:28 pm Purchase |
2021-12-31 | 13G | Vickers Vantage Corp. I VCKA |
CVI Investments, Inc. | 749,600 4.300% |
749,600 (New Position) |
Filing History |
| 2022-02-14 3:27 pm Purchase |
2021-12-31 | 13G | Ebang International Holdings Inc. EBON |
CVI Investments, Inc. | 343,333 6.900% |
343,333 (New Position) |
Filing History |
| 2022-02-14 3:27 pm Sale |
2021-12-31 | 13G | Caladrius Biosciences, Inc. CLBS |
CVI Investments, Inc. | 105,000 2.600% |
-95,000 (-47.50%) |
Filing History |
| 2022-02-14 3:26 pm Unchanged |
2021-12-31 | 13G | Benessere Capital Acquisition Corp. BENE |
CVI Investments, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 3:26 pm Purchase |
2021-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL |
CVI Investments, Inc. | 195 4.900% |
72 (+58.96%) |
Filing History |
| 2022-02-14 3:25 pm Sale |
2021-12-31 | 13G | Neovasc Inc. NVCN |
CVI Investments, Inc. | 102,500 3.700% |
-57,500 (-35.94%) |
Filing History |
| 2022-02-14 3:25 pm Purchase |
2021-12-31 | 13G | TG Venture Acquisition Corp. TGVC |
CVI Investments, Inc. | 538,069 4.700% |
538,069 (New Position) |
Filing History |
| 2022-02-14 3:25 pm Purchase |
2021-12-31 | 13G | Peraso Inc. PRSO |
CVI Investments, Inc. | 184 0.100% |
184 (New Position) |
Filing History |
| 2022-02-14 3:24 pm Purchase |
2021-12-31 | 13G | Clarus Therapeutics Holdings, Inc. CRXTQ |
CVI Investments, Inc. | 264,407 1.100% |
264,407 (New Position) |
Filing History |
| 2022-02-14 3:24 pm Sale |
2021-12-31 | 13G | Pyxis Tankers Inc. PXS |
CVI Investments, Inc. | 21,762 0.200% |
-692,524 (-96.95%) |
Filing History |
| 2022-02-14 3:23 pm Sale |
2021-12-31 | 13G | Cyren Ltd. CYRN |
CVI Investments, Inc. | 0 0.000% |
-225,000 (Position Closed) |
Filing History |
| 2022-02-14 3:23 pm Unchanged |
2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 2,316,165 3.700% |
0 (Unchanged) |
Filing History |
| 2022-02-14 3:23 pm Sale |
2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
CVI Investments, Inc. | 0 0.000% |
-4,000 (Position Closed) |
Filing History |
| 2022-02-14 3:22 pm Purchase |
2021-12-31 | 13G | Spring Valley Acquisition Corp. SV |
CVI Investments, Inc. | 1,887,541 8.200% |
1,887,541 (New Position) |
Filing History |
| 2022-02-14 3:22 pm Unchanged |
2021-12-31 | 13G | Staffing 360 Solutions, Inc. STAF |
CVI Investments, Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 3:21 pm Unchanged |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 40,000 3.600% |
0 (Unchanged) |
Filing History |
| 2022-02-14 3:21 pm Sale |
2021-12-31 | 13G | Red Cat Holdings, Inc. RCAT |
CVI Investments, Inc. | 0 0.000% |
-2,500,000 (Position Closed) |
Filing History |
| 2022-02-14 3:21 pm Sale |
2021-12-31 | 13G | Phunware, Inc. PHUN |
CVI Investments, Inc. | 0 0.000% |
-78,407 (Position Closed) |
Filing History |
| 2022-02-14 3:20 pm Sale |
2021-12-31 | 13G | Traws Pharma, Inc. TRAW |
CVI Investments, Inc. | 0 0.000% |
-47,000 (Position Closed) |
Filing History |